Therapy & Research
WHAT’S NEW
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
A new study of emergency first responders suggests that a single self-administered dose of psilocybin, the chief psychoactive comp...
POPULAR ARTICLES
First-Ever Professional Guidelines for Psychedelic-Assisted Therapy Practitioners Now Published by APPA and BrainFutures
The first-ever set of professional practice guidelines for psychedelic-assisted therapy were officially published today....
Read More
Psychedelics Can Be Used to Treat PTSD, Finds Yet Another Clinical Trial
New research indicates that people who were given controlled doses of ecstasy and magic mushrooms during post-traumatic stress dis...
Read More
Hidden Consciousness Exists in Humans, Scientists Say
A new study reveals unseen cognitive function in 25 percent of unresponsive patients....
Read More
Inside the Movement to Decolonize Psychedelic Pharma
As Western medicine brings psychedelics mainstream, a growing movement is innovating new business models grounded in reciprocity &...
Read More
A single, moderate dose of psilocybin reduces depressive symptoms for at least two weeks, controlled study finds
A single dose of the psychedelic drug psilocybin combined with supportive counseling leads to significant reductions in depressive...
Read More
California Senate Passes Bill To Legalize Psychedelics Possession And Facilitated Use
A California bill to legalize the possession of certain psychedelics and facilitated use of the substances has passed the Senate. ...
Read More